Outlook of Mergers & Acquisitions, Investments, and Patents in the 3D Printing Market (2010-2016)

  • ID: 3765646
  • Report
  • Region: Global
  • 128 Pages
  • Markets and Markets
1 of 5
The Global Bioabsorbable Stents Market is Expected to Reach USD 2.4 Billion by 2021 from USD 0.4 Billion by 2016, at a CAGR of 42.5% During the Forecast Period

FEATURED COMPANIES

  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Arterius Limited
  • Biotronik
  • Meril Life Sciences
  • Reva Medical, Inc.
  • MORE
GROWING ADVENT OF THE 3D PRINTING TECHNOLOGIES GENERATED INTERESTS AMONG MANY PLAYERS WORLDWIDE

The 3D printing market has witnessed tremendous growth in M&A activities in terms of the number of deals announced between 2010 and 2016. The large tech companies have shown interest in the 3D printing technology through various acquisitions. The driving factors behind the increase in M&A activities include the need to increase scale, substantial growth of startup companies, intense competition, and the need for companies to improve their technology, product, and services portfolio. Significant opportunities exist for the 3D printing market in the Asia-Pacific region. The market has been experiencing advancements in printers and printing technologies, improvements in materials used, and developments in skilled workforce.

3D PRINTING MARKET TO GROW AT A HIGH CAGR BETWEEN 2016 AND 2022

The 3D printing market is expected to reach USD 30.19 billion by 2022, at a CAGR of 28.5% between 2016 and 2022. 3D printing is used to develop prototypes and end products in industries such as automotive, medical, aerospace, defense, dental, biomedical, jewelry, art, architecture, fashion designing, and interior designing among others. Along with these, electronics, robotics, spacecraft, construction, organ transplantations, food, and other industries have also started adopting the 3D printing technology. The market is growing rapidly, and it is now focusing on the production of end parts with the development of technologies and metal powdered materials.

The break-up of profile of primary participants is given below:
- By Company Type: Tier 1 – 25%, Tier 2 – 45% and Tier 3 –30%
- By Designation: C-Level – 35%, Director Level – 40%, Others – 25%
- By Region: North America – 45%, Europe – 35%, APAC – 15%, RoW – 5%
The major players in the 3D printing market include 3D Systems Corporation (U.S.), Stratasys Ltd. (U.S. & Israel), the ExOne Company(U.S.), Voxeljet AG (Germany), Arcam Group (Sweden), SLM Solutions Group AG (Germany), EOS GmbH (Germany), EnvisionTEC GmbH (Germany), Materialise NV (Belgium), Sciaky Inc. (U.S.), Concept Laser GmbH (Germany), Autodesk, Inc. (U.S.), Hoganas AB (Sweden), Renishaw PLC (U.K.).

The report will help leaders/new entrants in this market in the following ways:

1. This report categorizes M&A during 2010–2016 by deal volume, segment, cross-border and domestic, and geography with a review of the big deals giving buyers an insight into the latest M&A trends in the 3D printing market.
2. The report provides an overview of the 3D printing market, analyzing key component segments and end-user segments. Furthermore, stakeholders can get an understanding of the pulse of M&A, patents, and investments.
3. The report reviews key M&A strategies, private equity investors, and patents adopted by top 3D printing companies and analyzes the top five assignees of the published patents.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Arterius Limited
  • Biotronik
  • Meril Life Sciences
  • Reva Medical, Inc.
  • MORE
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Bioabsorbable Stents Market, By Material
4.2 Bioabsorbable Stents Market, By Absorption Rate
4.3 Bioabsorbable Stents Market, By End User
4.4 Bioabsorbable Stents Market, By Region

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapidly Growing Aging Population and Increased Risk of Coronary Artery Disease and Peripheral Artery Disease in the Elderly
5.2.1.2 Strong Product Pipeline
5.2.2 Restraints
5.2.2.1 High Device Costs
5.2.3 Opportunities
5.2.3.1 Emerging Markets to Offer High-Growth Opportunities for Market Players
5.2.4 Challenges
5.2.4.1 Presence of Substitutes
5.2.4.2 High Risk of Complications

6 Regulatory Scenario
6.1 Introduction
6.2 FDA and CE Approvals
6.3 PMA Approvals and Government Certificates

7 Bioabsorbable Stents Market, Pipeline Products
7.1 Introduction
7.2 Patents

8 Bioabsorbable Stents Market, By Material
8.1 Introduction
8.2 Polymeric Stents
8.3 Metallic Stents

9 Bioabsorbable Stents Market, By Absorption Rate
9.1 Introduction
9.2 Slow-Absorption Stents
9.3 Fast-Absorption Stents

10 Bioabsorbable Stents Market, By Drug
10.1 Introduction
10.2 Paclitaxel
10.3 Limus-Based Drugs

11 Bioabsorbable Stents Market, By Application
11.1 Introduction
11.2 Coronary Artery Disease
11.3 Peripheral Artery Disease

12 Bioabsorbable Stents Market, By End User
12.1 Introduction
12.2 Hospitals
12.3 Cardiac Centers

13 Bioabsorbable Stents Market, By Region
13.1 Introduction
13.2 North America
13.2.1 U.S.
13.2.2 Canada
13.3 Europe
13.3.1 Germany
13.3.2 France
13.3.3 U.K.
13.3.4 Rest of Europe (RoE)
13.4 Asia
13.4.1 Japan
13.4.2 China
13.4.3 India
13.4.4 Rest of Asia
13.5 Rest of the World

14 Competitive Landscape
14.1 Overview
14.2 Market Share Analysis
14.3 Competitive Situations & Trends
14.3.1 New Product Launches & Product Approvals
14.3.2 Agreements
14.3.3 Investments

15 Company Profiles
(Company at A Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MnM View)*
15.1 Introduction
15.2 Abbott Laboratories
15.3 Reva Medical, Inc.
15.4 Elixir Medical Corporation
15.5 Kyoto Medical Planning Co., Ltd.
15.6 Amaranth Medical, Inc.
15.7 Arterial Remodeling Technologies
15.8 Biotronik
15.9 Xenogenics Corporation (A Subsidiary of Multicell Technologies, Inc.)
15.10 Meril Life Sciences
15.11 SMT (Part of Sahajanand Group of Companies)
15.12 Tepha, Inc.
15.13 Arterius Limited

*Details on Company at A Glance, Recent Financials, Products Offered, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

16 Appendix
16.1 Insights From Industry Experts
16.2 Discussion Guide
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
- Abbott Laboratories
- Amaranth Medical, Inc.
- Arterial Remodeling Technologies
- Arterius Limited
- Biotronik
- Elixir Medical Corporation
- Kyoto Medical Planning Co., Ltd.
- Meril Life Sciences
- Reva Medical, Inc.
- SMT (Part of Sahajanand Group of Companies)
- Tepha, Inc.
- Xenogenics Corporation (A Subsidiary of Multicell Technologies, Inc.)
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll